Novartis is laying off 322 employees at its U.S. headquarters. The cuts are scheduled to take effect by October 2. The company cited changes in sales, patient support, and marketing. This represents the fourth round of dismissals at the East Hanover site. Novartis is adjusting operations due to patent expirations and restructuring efforts.
East Hanover, New Jersey
https://www.fiercepharma.com/pharma/novartis-dismisses-322-more-its-us-headquarters-nj